Health
Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma – News-Medical.Net
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment…
Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment combination.
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
Continue Reading
-
General6 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News15 hours agoRainbow Beach surfer’s untold 7/7 story
-
General22 hours agoParis opens River Seine for public swimming for first time since 1923